Li, D., Silvester, J. A., Crowley, M. J., Yang, J. Y., Alexopoulos, A.-S., Xu, Y., … Wang, T. (2020). Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting. Ther Adv Chronic Dis, 11, 2040622320904301. https://doi.org/10.1177/2040622320904301

Li, Dandan, Jocelyn Anne Silvester, Matthew J. Crowley, Jeff Y. Yang, Anastasia-Stefania Alexopoulos, Yang Xu, Siyan Zhan, and Tiansheng Wang. “Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting.” Ther Adv Chronic Dis 11 (2020): 2040622320904301. https://doi.org/10.1177/2040622320904301.

Li D, Silvester JA, Crowley MJ, Yang JY, Alexopoulos A-S, Xu Y, et al. Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting. Ther Adv Chronic Dis. 2020;11:2040622320904301.

Li, Dandan, et al. “Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting.” Ther Adv Chronic Dis, vol. 11, 2020, p. 2040622320904301. Pubmed, doi:10.1177/2040622320904301.

Li D, Silvester JA, Crowley MJ, Yang JY, Alexopoulos A-S, Xu Y, Zhan S, Wang T. Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting. Ther Adv Chronic Dis. 2020;11:2040622320904301.